Publication date: September 2026 Source: European Urology Focus, Volume 12, Issue 4 Author(s): Tessa van Elst, Pedro Lopez, Laurien M. Buffart, Jose A.E. Custers, Lieke Wever, Jippe C. de Bie, Peter F.A. Mulders, Haiko J. Bloemendal, Jean-Paul A. van Basten, Niven Mehra
Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis. // European Urology Focus. – URL: https://www.sciencedirect.com/science/article/pii/S2405456925003529?dgcid=rss_sd_all
Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis. European Urology Focus. https://www.sciencedirect.com/science/article/pii/S2405456925003529?dgcid=rss_sd_all
“Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis.” European Urology Focus.
@article{article118612,
title = {Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis},
journal = {European Urology Focus},
url = {https://www.sciencedirect.com/science/article/pii/S2405456925003529?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...